17 June 2019
Chemicals compliance
Last 23 May 2019, Reg 831/2019 (or Omnibus Act) was published in the Official Journal of the European Union.
This is a regulatory update with very important implications about the use of numerous substances evaluated as carcinogenic, mutagenic or toxic for reproduction (CMR).
These substances, considered as such pursuant to Regulation (EC) No. 1272/2008, have always been prohibited in cosmetic products (art. 15 of Reg. 1223/2009), especially those of class 1A and 1B, while those belonging to class 2 could be used exceptionally, following approval by SCCS.
The need of a legislative adjustment about these substances arose from the fact that they were prohibited by Article 15 of the Regulation, but they did not appear, or at least not all of them, in Annex II, creating an unclear regulatory situation and a risk of ambiguity.
The Omnibus Act is the European regulation with which all the substances classified as CMR pass automatically into Annex II and are formally prohibited for cosmetic use. The news regulation also transfers in Annex III the CMR substances with possible use following authorization by SCCS.
The decree entered into force on 12 June 2019.
A complete list of substances is reported in the Annex of the Regulation.
Contact prodotto@ceprasrl.it for more information.
04 April 2024
Chemicals compliance
On 3 April 2024, Regulation 2024/996 amending Annexes II, III, V and VI of Regulation (EC) No 1223/2009 was published. Below is the list of the amendments: Annex II (prohibited substances): the substance...
18 March 2024
Chemicals compliance
On 15 March 2024, Regulation 2024/858 was published, amending Annexes II and III of Regulation 1223/2009 with regard to certain nanomaterials. The following have been added to Annex II (and are therefore...